Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Garcia

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Are new oral anticoagulants ready for use in patients with cancer?Paul C Hendrie, David A Garcia
Seminars in Respiratory and Critical Care Medicine|February 28, 2008
Update in the treatment of venous thromboembolismDavid A Garcia, Alex C Spyropoulos
Archives of Internal Medicine|August 28, 2002
A survey of oral vitamin K use by anticoagulation clinicsEdward N Libby, David A Garcia
Seminars in Thrombosis and Hemostasis|February 8, 2013
The novel oral anticoagulantsCristhiam M Rojas-Hernandez, David A Garcia
Current Opinion in Structural Biology|July 25, 2021
Phase separation in transcription factor dynamics and chromatin organizationKaustubh Wagh, David A Garcia, Arpita Upadhyaya
Hematology/Oncology Clinics of North America|September 18, 2016
Use of Direct Oral Anticoagulants in Special PopulationsAng Li, Renato D Lopes, David A Garcia
Blood|January 4, 2014
How I treat target-specific oral anticoagulant-associated bleedingDeborah M Siegal, David A Garcia, Mark A Crowther
Journal of Thrombosis and Thrombolysis|January 3, 2019
Assessment of direct oral anticoagulant assay use in clinical practiceTina M Gu, David A Garcia, Daniel E Sabath
Blood|July 24, 2007
How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based reviewDavid A Garcia, Munther A Khamashta, Mark A Crowther
Thrombosis and Haemostasis|October 2, 2010
New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugsDavid A Garcia, Renato D Lopes, Elaine M Hylek
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Are new oral anticoagulants ready for use in patients with cancer?Paul C Hendrie, David A Garcia
Seminars in Respiratory and Critical Care Medicine|February 28, 2008
Update in the treatment of venous thromboembolismDavid A Garcia, Alex C Spyropoulos
Archives of Internal Medicine|August 28, 2002
A survey of oral vitamin K use by anticoagulation clinicsEdward N Libby, David A Garcia
Seminars in Thrombosis and Hemostasis|February 8, 2013
The novel oral anticoagulantsCristhiam M Rojas-Hernandez, David A Garcia
Current Opinion in Structural Biology|July 25, 2021
Phase separation in transcription factor dynamics and chromatin organizationKaustubh Wagh, David A Garcia, Arpita Upadhyaya
Hematology/Oncology Clinics of North America|September 18, 2016
Use of Direct Oral Anticoagulants in Special PopulationsAng Li, Renato D Lopes, David A Garcia
Blood|January 4, 2014
How I treat target-specific oral anticoagulant-associated bleedingDeborah M Siegal, David A Garcia, Mark A Crowther
Journal of Thrombosis and Thrombolysis|January 3, 2019
Assessment of direct oral anticoagulant assay use in clinical practiceTina M Gu, David A Garcia, Daniel E Sabath
Blood|July 24, 2007
How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based reviewDavid A Garcia, Munther A Khamashta, Mark A Crowther
Thrombosis and Haemostasis|October 2, 2010
New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugsDavid A Garcia, Renato D Lopes, Elaine M Hylek
Pageof 10